Company Cell Therapeutics Inc Nasdaq
Equities
US1509348835
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2023 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
2023 | DRI Healthcare Trust Brief: Announcing US$54.8 Million Debt Repayment from CTI BioPharma Corp. | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 17-03-19 |
David Kirske
DFI | Director of Finance/CFO | 69 | 17-07-31 |
John Volpone
HRO | Human Resources Officer | - | - |
Jim Fong
PRN | Corporate Officer/Principal | 62 | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 17-03-19 |
David Parkinson
BRD | Director/Board Member | 73 | 17-06-04 |
Reed Tuckson
BRD | Director/Board Member | 73 | 11-08-31 |
Diane Parks
BRD | Director/Board Member | 71 | 21-08-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,047 | 0 | 0 | 95.47 % |
Stock B | 1 | 131,880,176 | 125,911,110 ( 95.47 %) | 0 |
Company contact information
CTI BioPharma Corp.
3101 Western Avenue Suite 800
98121, Seattle
+206 282 7100
http://www.ctibiopharma.com![address Cell Therapeutics Inc](https://cdn.zonebourse.com/static/address/11410634.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- CTIC Stock
- Stock
- Company Cell Therapeutics Inc